TY - JOUR
T1 - Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands
AU - Gulley, Joshua M.
AU - Zahniser, Nancy R.
N1 - Funding Information:
We gratefully acknowledge support from the National Institute on Drug Abuse (DA 04216 and DA 15050).
PY - 2003/10/31
Y1 - 2003/10/31
N2 - The extracellular actions of dopamine are terminated primarily through its binding to dopamine transporters and translocation back into dopamine neurons. The transporter thereby serves as an optimal target to regulate dopamine neurotransmission. Although acute pharmacological blockade of dopamine transporters is known to reversibly inhibit transporter function by preventing the binding of its endogenous substrate dopamine, it recently has become clear that dopamine transporter substrates, such as amphetamines, and blockers, such as cocaine, also have the ability to rapidly and persistently regulate transporter function after their direct pharmacological effect has subsided. Presynaptic receptor ligands can also regulate dopamine transporter function. This has been investigated most extensively for dopamine D2 receptors, but there is also evidence for regulation by γ-aminobutyric acid (GABA) GABAB receptors, metabotropic glutamate, nicotinic acetylcholine, serotonin, σ2- and κ-opioid receptors. The focus of this review is the rapid, typically reversible, regulation of dopamine transporter velocity by substrates, blockers and presynaptic receptor ligands. The research discussed here suggests that a common mechanism through which these different classes of compounds regulate transporter activity is by altering the cell surface expression of dopamine transporters.
AB - The extracellular actions of dopamine are terminated primarily through its binding to dopamine transporters and translocation back into dopamine neurons. The transporter thereby serves as an optimal target to regulate dopamine neurotransmission. Although acute pharmacological blockade of dopamine transporters is known to reversibly inhibit transporter function by preventing the binding of its endogenous substrate dopamine, it recently has become clear that dopamine transporter substrates, such as amphetamines, and blockers, such as cocaine, also have the ability to rapidly and persistently regulate transporter function after their direct pharmacological effect has subsided. Presynaptic receptor ligands can also regulate dopamine transporter function. This has been investigated most extensively for dopamine D2 receptors, but there is also evidence for regulation by γ-aminobutyric acid (GABA) GABAB receptors, metabotropic glutamate, nicotinic acetylcholine, serotonin, σ2- and κ-opioid receptors. The focus of this review is the rapid, typically reversible, regulation of dopamine transporter velocity by substrates, blockers and presynaptic receptor ligands. The research discussed here suggests that a common mechanism through which these different classes of compounds regulate transporter activity is by altering the cell surface expression of dopamine transporters.
KW - DAT (dopamine transporter)
KW - Functional regulation
KW - Presynaptic receptor
KW - Substrate-mediated regulation
KW - Trafficking
UR - http://www.scopus.com/inward/record.url?scp=0242492013&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0242492013&partnerID=8YFLogxK
U2 - 10.1016/j.ejphar.2003.08.064
DO - 10.1016/j.ejphar.2003.08.064
M3 - Article
C2 - 14612145
AN - SCOPUS:0242492013
SN - 0014-2999
VL - 479
SP - 139
EP - 152
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 1-3
ER -